Utah Retirement Systems’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $6.09M | Sell |
20,236
-365
| -2% | -$110K | 0.06% | 284 |
|
|
2026
Q1 | $6.82M | Sell |
20,601
-124
| -0.6% | -$42.2K | 0.07% | 259 |
|
|
2025
Q4 | $8.24M | Buy |
20,725
+126
| +0.6% | +$55.8K | 0.08% | 225 |
|
|
2025
Q3 | $9.39M | Sell |
20,599
-371
| -2% | -$151K | 0.09% | 202 |
|
|
2025
Q2 | $6.84M | Sell |
20,970
-355
| -2% | -$98.2K | 0.07% | 261 |
|
|
2025
Q1 | $5.76M | Hold |
21,325
| – | – | 0.07% | 272 |
|
|
2024
Q4 | $5.02M | Buy |
21,325
+400
| +2% | +$105K | 0.06% | 320 |
|
|
2024
Q3 | $5.76M | Buy |
20,925
+200
| +1% | +$52.1K | 0.06% | 285 |
|
|
2024
Q2 | $5.04M | Sell |
20,725
-800
| -4% | -$126K | 0.06% | 295 |
|
|
2024
Q1 | $3.22M | Buy |
21,525
+100
| +0.5% | +$16.7K | 0.04% | 422 |
|
|
2023
Q4 | $4.1M | Buy |
21,425
+100
| +0.5% | +$17K | 0.05% | 345 |
|
|
2023
Q3 | $3.78M | Buy |
21,325
+100
| +0.5% | +$19.1K | 0.05% | 342 |
|
|
2023
Q2 | $4.03M | Sell |
21,225
-600
| -3% | -$119K | 0.06% | 345 |
|
|
2023
Q1 | $4.37M | Buy |
21,825
+54
| +0.2% | +$11.4K | 0.06% | 325 |
|
|
2022
Q4 | $5.17M | Buy |
21,771
+199
| +0.9% | +$42.4K | 0.08% | 258 |
|
|
2022
Q3 | $4.32M | Buy |
21,572
+200
| +0.9% | +$38.1K | 0.07% | 279 |
|
|
2022
Q2 | $3.12M | Hold |
21,372
| – | – | 0.05% | 361 |
|
|
2022
Q1 | $3.49M | Sell |
21,372
-100
| -0.5% | -$15.2K | 0.05% | 382 |
|
|
2021
Q4 | $3.64M | Hold |
21,472
| – | – | 0.05% | 396 |
|
|
2021
Q3 | $4.05M | Sell |
21,472
-800
| -4% | -$150K | 0.05% | 345 |
|
|
2021
Q2 | $3.77M | Buy |
22,272
+100
| +0.5% | +$14.6K | 0.05% | 388 |
|
|
2021
Q1 | $3.13M | Sell |
22,172
-1,000
| -4% | -$150K | 0.04% | 415 |
|
|
2020
Q4 | $3.01M | Buy |
23,172
+1,000
| +5% | +$134K | 0.04% | 413 |
|
|
2020
Q3 | $3.23M | Buy |
22,172
+400
| +2% | +$56.8K | 0.05% | 335 |
|
|
2020
Q2 | $3.23M | Buy |
21,772
+1,600
| +8% | +$216K | 0.06% | 311 |
|
|
2020
Q1 | $2.2M | Hold |
20,172
| – | – | 0.05% | 361 |
|
|
2019
Q4 | $2.32M | Buy |
20,172
+100
| +0.5% | +$9.97K | 0.04% | 433 |
|
|
2019
Q3 | $1.61M | Buy |
20,072
+500
| +3% | +$39.6K | 0.03% | 545 |
|
|
2019
Q2 | $1.42M | Buy |
19,572
+1,759
| +10% | +$135K | 0.03% | 599 |
|
|
2019
Q1 | $1.67M | Buy |
17,813
+1,113
| +7% | +$93.1K | 0.03% | 516 |
|
|
2018
Q4 | $1.22M | Buy |
16,700
+100
| +0.6% | +$7.69K | 0.03% | 568 |
|
|
2018
Q3 | $1.45M | Buy |
16,600
+100
| +0.6% | +$10.1K | 0.03% | 584 |
|
|
2018
Q2 | $1.63M | Buy |
16,500
+300
| +2% | +$29.8K | 0.03% | 525 |
|
|
2018
Q1 | $1.93M | Buy |
16,200
+200
| +1% | +$25.8K | 0.04% | 451 |
|
|
2017
Q4 | $2.03M | Buy |
16,000
+1,400
| +10% | +$176K | 0.04% | 438 |
|
|
2017
Q3 | $1.72M | Buy |
14,600
+800
| +6% | +$68.3K | 0.04% | 469 |
|
|
2017
Q2 | $1.1M | Buy |
13,800
+200
| +1% | +$12.8K | 0.03% | 628 |
|
|
2017
Q1 | $697K | Hold |
13,600
| – | – | 0.02% | 781 |
|
|
2016
Q4 | $510K | Sell |
13,600
-100
| -0.7% | -$4.19K | 0.01% | 864 |
|
|
2016
Q3 | $928K | Hold |
13,700
| – | – | 0.02% | 654 |
|
|
2016
Q2 | $760K | Buy |
13,700
+400
| +3% | +$25.2K | 0.02% | 720 |
|
|
2016
Q1 | $835K | Hold |
13,300
| – | – | 0.02% | 678 |
|
|
2015
Q4 | $1.25M | Hold |
13,300
| – | – | 0.03% | 525 |
|
|
2015
Q3 | $1.07M | Buy |
13,300
+100
| +0.8% | +$11.1K | 0.03% | 579 |
|
|
2015
Q2 | $1.58M | Buy |
13,200
+300
| +2% | +$35.9K | 0.04% | 461 |
|
|
2015
Q1 | $1.35M | Buy |
12,900
+1,400
| +12% | +$142K | 0.04% | 536 |
|
|
2014
Q4 | $1.11M | Hold |
11,500
| – | – | 0.03% | 570 |
|
|
2014
Q3 | $898K | Hold |
11,500
| – | – | 0.03% | 635 |
|
|
2014
Q2 | $726K | Buy |
+11,500
| New | +$684K | 0.02% | 765 |
|
Other funds holding ALNY
Utah Retirement Systems's ALNY Position: Q2 2026 in Review
Utah Retirement Systems reduced its Alnylam Pharmaceuticals (ALNY) stake by 1.8% in Q2 2026, selling an estimated $110K and leaving 20,236 shares worth $6.09M. The position accounts for 0.06% of the portfolio, ranked #284.
Utah Retirement Systems first reported a position in ALNY in Q2 2014 and has held it in 49 quarters since. The position peaked at $9.39M in Q3 2025. 785 funds tracked by Wall St. Rank hold ALNY as of Q2 2026.
- Utah Retirement Systems held 20,236 shares of Alnylam Pharmaceuticals worth $6.09M as of Q2 2026.
- Utah Retirement Systems sold 365 Alnylam Pharmaceuticals shares in Q2 2026, an estimated $110K.
- Alnylam Pharmaceuticals made up 0.06% of Utah Retirement Systems's portfolio in Q2 2026, its #284 holding.
- Utah Retirement Systems first reported a position in Alnylam Pharmaceuticals in Q2 2014 and has held it in 49 quarters since.
- Utah Retirement Systems's Alnylam Pharmaceuticals position peaked at $9.39M in Q3 2025.
- 785 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2026.
Based on Utah Retirement Systems's 13F filing for Q2 2026, filed 14 Aug 2026.